Terifrac Solo 600mcg Injection Teriparatide

Terifrac Solo 600mcg Injection contains teriparatide, a recombinant parathyroid hormone analog used in the treatment of osteoporosis. It is an anabolic (bone-building) therapy that helps increase bone mineral density and reduce the risk of fractures in patients with weakened bones.

This injection is commonly prescribed for postmenopausal women, men with osteoporosis, and patients at high risk of fractures due to long-term corticosteroid use or other bone-related conditions.

How it works

Teriparatide stimulates osteoblast activity, promoting the formation of new bone. Unlike antiresorptive therapies, it actively builds bone and improves bone structure.

• Osteoporosis in postmenopausal women
• Osteoporosis in men at high fracture risk
• Bone loss due to long-term steroid use

Benefits

• Stimulates new bone formation
• Increases bone density and strength
• Reduces risk of fractures
• Effective in severe osteoporosis cases

Administered as a subcutaneous injection, usually once daily. Dosage and duration depend on the patient’s condition. Use under medical supervision.